The aim of this study was to determine the relationships between p-STAT3, c-Myc and P2-HNF4α expression in biopsies from livers with NAFLD as potential biomarkers of HCC risk. Here, HNF4A is linked to metabolic dysfunction-associated steatotic liver disease.